Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SpaceIT Hydrogel System for Perirectal Spacing

NCT: NCT06451614 · ACTIVE_NOT_RECRUITING

NCT IDNCT06451614
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-30
Completion2028-03-31
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑